TrialJCO precision oncology2021

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.

Jessica L Fleming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.